News

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Weighty issue
Concerns over new age weight loss, diabetes drugs ...
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
The plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...